Inozyme Pharma (INZY) Earnings Date, Estimates & Call Transcripts $0.88 -0.03 (-3.22%) Closing price 04:00 PM EasternExtended Trading$0.89 +0.01 (+1.17%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Inozyme Pharma Earnings Summary Upcoming Q4 Earnings DateMay. 6Before Market OpensEstimatedConsensus EPS (Nov. 5) -$0.44 Actual EPS (Nov. 5) -$0.39 Beat By $0.05 Inozyme Pharma released Q3 2024 earnings on November 5, 2024, reporting an EPS of -$0.39, which beat the consensus estimate of -$0.44 by $0.05. With a trailing EPS of -$1.63, Inozyme Pharma's earnings are expected to decrease next year, from ($1.59) to ($1.64) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings Report Press Release (8-K) Quarterly Report (10-Q)INZY Upcoming EarningsInozyme Pharma's Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Inozyme Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inozyme Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINZY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Inozyme Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.44-$0.43-$0.44Q2 20252-$0.40-$0.25-$0.33Q3 20252-$0.35-$0.25-$0.30Q4 20252-$0.25-$0.25-$0.25FY 20258($1.44)($1.18)($1.31) Remove Ads Inozyme Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------11/5/2024--$0.44-$0.39+$0.05-$0.39--8/6/2024--$0.37-$0.44 -$0.07-$0.44--5/7/2024Q1 2024-$0.35-$0.38 -$0.03-$0.38--3/12/2024Q4 2023-$0.31-$0.35 -$0.04-$0.35--11/7/2023Q3 2023-$0.32-$0.29+$0.03-$0.29--8/8/2023Q2 2023-$0.43-$0.35+$0.08-$0.35--5/9/2023Q1 2023-$0.44-$0.40+$0.04-$0.40-- Inozyme Pharma Earnings - Frequently Asked Questions When is Inozyme Pharma's earnings date? Inozyme Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on INZY's earnings history. Did Inozyme Pharma beat their earnings estimates last quarter? In the previous quarter, Inozyme Pharma (NASDAQ:INZY) reported ($0.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.44) by $0.05. Learn more on analysts' earnings estimate vs. INZY's actual earnings. How much profit does Inozyme Pharma generate each year? Inozyme Pharma (NASDAQ:INZY) has a recorded net income of -$71.17 million. INZY has generated -$1.63 earnings per share over the last four quarters. What is Inozyme Pharma's EPS forecast for next year? Inozyme Pharma's earnings are expected to decrease from ($1.59) per share to ($1.64) per share in the next year. More Earnings Resources from MarketBeat Related Companies CADL Earnings SLDB Earnings ACB Earnings OLMA Earnings CMPX Earnings DRUG Earnings FHTX Earnings MBX Earnings ITOS Earnings CRVS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:INZY) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump’s policies mean HUGE income for investorsThanks to a Trump win… Investors have a HUGE opportunity at new income. The floodgates for U.S. oil prod...The Oxford Club | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored6 stocks could soar on DOGE AI news …Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inozyme Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inozyme Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INZY Stock Free INZY Stock Alerts